A new Phase 2 clinical trial, DOMMINO-1, is now recruiting people living with advanced multiple myeloma who have already received several prior treatments. This study is evaluating inobrodib in combination with pomalidomide and dexamethasone to better understand how this approach may work for patients whose disease has become more difficult to treat. Learn more about participation and see if this study could be an option for you: https://clinicaltrials.gov/study/NCT07096778 clinical@cellcentric.com +44 1799 531130